Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M298Revenue $M7.9Net Margin (%)-541.5Z-Score0.9
Enterprise Value $M204EPS $-0.8Operating Margin %-546.7F-Score3
P/E(ttm))0Cash Flow Per Share $0.4Pre-tax Margin (%)-546.1Higher ROA y-yY
Price/Book2.710-y EBITDA Growth Rate %0Quick Ratio13.0Cash flow > EarningsY
Price/Sales34.15-y EBITDA Growth Rate %0Current Ratio13.3Lower Leverage y-yN
Price/Cash Flow6.4y-y EBITDA Growth Rate %0ROA % (ttm)-37.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-53.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M60.8ROI % (ttm)-48.7Gross Margin Increase y-yN

Gurus Latest Trades with PGNX

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PGNXJohn Hussman 2009-06-30 Sold Out -0.02%$4.53 - $6.84
($5.48)
$ 4.28-22%Sold Out0
PGNXJohn Hussman 2008-09-30 Buy 0.04%$12.19 - $17.07
($14.9)
$ 4.28-71%New holding, 100000 sh.100,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PGNX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


PGNX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ISRAEL ROBERT JSenior VP Medical Affairs 2013-07-18Sell5,000$6.33-34.44 view
Baker Mark RobertCEO 2013-03-27Buy650$5.32-21.99 view
Baker Mark RobertCEO 2013-02-27Buy1,262$2.7252.57 view
Baker Mark RobertCEO 2013-01-22Buy1,215$2.8247.16 view
Baker Mark RobertCEO 2012-12-26Buy1,142$3.0137.87 view
Baker Mark RobertCEO 2012-11-28Buy1,607$2.1394.84 view
Baker Mark RobertCEO 2012-11-19Buy11,800$1.96111.73 view
Baker Mark RobertCEO 2012-11-16Buy49,793$1.82128.02 view
Baker Mark RobertCEO 2012-11-15Buy48,833$1.69145.56 view
Baker Mark RobertCEO 2012-10-24Buy1,162$2.9640.2 view

Press Releases about PGNX :

    Quarterly/Annual Reports about PGNX:

    News about PGNX:

    Articles On GuruFocus.com
    Weekly CEO Buys Highlight: CVRR, HBAN, VVTV, SXCP, PGNX Jan 26 2013 
    Weekly CEO Buys Highlight: CVRR, HBAN, VVTV, SXCP, PGNX Jan 27 2013 
    Weekly CEO Buys Highlight: SUSP, ROVI, ZLC, MDW, PGNX Oct 01 2012 
    5 Stocks That Dropped the Most Since Gurus Bought Them Sep 13 2012 
    Dendreon Could Push Higher If New Drug Trials Succeed Apr 23 2012 
    Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Dec 01 2010 
    Progenics Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 08 2010 
    Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Nov 02 2010 
    Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Oct 04 2010 
    Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Sep 02 2010 

    More From Other Websites
    Another good find in specialty pharma Jul 03 2014
    PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers,... Jun 18 2014
    What Does A Positive Adcom Mean For Progenics And Salix? Jun 17 2014
    [$$] Two Undervalued Biopharmas to Buy Now Jun 13 2014
    Progenics Pharmaceuticals, Inc. (PGNX) in Focus: Stock Rises 9.23% Jun 13 2014
    PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 12 2014
    Progenics Schedules Investor Conference Call Following FDA Advisory Committee Jun 12 2014
    Salix says 'pleased' with FDA Ad Comm recommendations on PAMORAS Jun 12 2014
    Progenics, Nektar Still Halted; FDA Advisory Committee Expected To Conclude Thursday Jun 12 2014
    PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 11 2014
    Progenics Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Consider and Provide... Jun 11 2014
    PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 10 2014
    Mid-Afternoon Market Update; Hertz Down, QuikSilver Gain On CEO & CFO Share Purchases Jun 06 2014
    Mid-Day Market Update: Diamond Foods Shares Fall After Weak Earnings; GW Pharma Gains Jun 06 2014
    Progenics Pharmaceuticals (PGNX) in Focus: Stock Falls 5.5% Jun 05 2014
    PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 03 2014
    Progenics Pharmaceuticals CEO Mark Baker to Present at Jefferies Global Healthcare Conference Jun 02 2014
    The IBB Likely To Move Higher Along With These Biotechs With Catalysts Upcoming Jun 02 2014
    PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 30 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide